Financial, market and economic news

Dr Reddys Labs spurts on launching OTC eye allergy drop in US

Dr Reddys Laboratories jumped 3.24% to Rs 4,781.40 after the drug major announced the launch of over-the-counter Olopatadine Hydrochloride Ophthalmic Solution in the US market.

Read More

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More

Privacy & Cookies Policy